Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
FACTS
1. CannEpil® is a Phytocannabinoid derived IMP used as a treatment for refractory epilepsy
* Available to prescribe in Australia and UK as an Investigational Medicinal Product through early patient access schemes
2.CogniCann® is MGC Pharma’s second Phytocannabinoid derived IMP designed to improve dementia and Alzheimer’s disease patients quality of life
*Available to prescribe in Australia as an Investigational Medicinal Product through Early Patient Access Scheme
MGC Pharma has a growing patient base in Australia, the UK, Brazil, and Ireland and has a global distribution footprint via
an extensive network of commercial partners meaning that it is poised to supply the global market.
These products are the outcome of years of experience and development of our medical team, produced under strict GMP guidelines with QA/QC/QP controls and audit
Slovenian EU-GMP certified facility has the capacity to manufacture up to 12,000 prescription products per month – 3 years GMP license granted.
Based on 5,000 units per month, the Company would be at operating cash flow breakeven, excluding Research costs.
Extensive network in place providing access to hospitals, pharmacies, and research institutions around the world – Lenis is
the Company’s wholesaler/exporter to all distributors globally and is also a direct distributor to key European markets. The
Acquisition of Medicinal Cannabis Clinics also provides distribution and direct patient access across Australia
QUALIFIED MANUFACTURING
• EU-GMP certification granted at Slovenian facility for production of phytocannabinoid based Investigational Medicinal Products (Europe)
• Production capabilities at the Malta facility,
once operational, is to support over 5,000 patient per month at full capacity1
• SME approval by the European Medicines Agency (EMA) for scientific advice and incentives
CogniCann:
Date of first participant enrolment
Anticipated 1/07/2019 Actual 2/09/2019
Date of last participant enrolment
Anticipated 20/12/2019 Actual ?
Date of last data collection
Anticipated 9/04/2020 Actual ?
Sample size
Target 50 Accrual to date 1
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=375128
Good luck tracking down any information related to 1st phase on any of their products.
Spot on Ehsan, don't let these mugs make you question your judgement.
Delayed by covid https://www.miragenews.com/perth-based-cannabis-trial-forges-522945/
I can see someone in a green box here. I don't know what you are saying, fortunately.
but speak with FACTS
Tanks Ironaz
Hi BigBob, the recruiting with some leeway, was to be completed prior to the covid situation, nice of the company to provide you with an excuse just yesterday. Forge ahead.
Smlfry
Have you bought more pins for your MGC voodoo doll???
Hi Irontaz, it's some good reading eh...
Did you see this one?...
27/02/21
"When Mitchell was at SAS, they raised around $40 million, dangling the carrot of estimating between $600 to a billion in revenue a year with a constellation of over the counter satellites. They launched just one inferior design to blah blah, bs the market that they were a real outfit. These figures were used over and again until the ASX requested clarity on the numbers. In one year alone, 4 directors gouged some $11 million in cash and shares. Many were banging their heads, trying to warn those sucked in by the bull**** but the response was exactly like yours is today. You're just trolling them for cheaper stock. History now shows that it was no different to the many both before and after which were ramped to the moon with total bs then ceased to trade. In the case of SAS, Mitchell even sold a hidden holding from Lancaster Equity during this period. I suspect that if anyone cared to check the registry of MXC, he'll have done the very same. Very smart operator who knows which buttons to press and the result is always the same. It a totally legal accumulation of vast sums at the expense of those calling the majority in here trolls. CTR, another Mitchell stock and once again, no longer trading, rolled an oil asset, spent $25 million of investors capital drilling a couple of oil wells then handed it back to a mate of former director (Greg Smith). A total scam, the wells are now cranking for the original owners and good old Brett sailed off into the sunset. Two of his former colleagues are currently facing fraud and stealing charges in the WA courts. It's just like ground hog day with every stock he's involved with. There will always be 3 types posting on
Mitchell stocks, those whom have no idea who they've jumped into bed with, insiders pumping to keep the hope alive and those whom have been bitten before.....The latter unfortunately represents a very large collective sum lost indeed. Can you guess where a decent percent went? Welcome to ground hog day!"
Hey smlfry! Feels like we are sitting around a campfire again, this time we are on the other side of it, deja vu ??
Does this feel just like Hotcopper, a couple of uprampers *cough brokers cough mxc insiders* doing their best to stop retail investors from being persuaded by posters who know this company and their M.O. ??
Hey StockWhisperer, (um PH6?) yes the similarity's are uncanny.
Even though I closed my share trading and hotcopper acct down and don't follow this scene anymore (I made bank on an mxc pump) , out of interest I thought I'd pop over here and take a look at how this LSE listing unfolds. I find it all quite fascinating really. How they have kept the train on the tracks amazes me. I guess theres enough suckers born every minute.
I hear ya, I finally got off too, I almost convinced myself the poms will push it further, but when it hit 52 week high 3/4 days in a row, then 5 year high, something came over me and hitting the sell button came with ease. Came to tell the Poms of my experience riding the Brett express.
Ehsan, you've got a friend over on the Aus forum...
"Hey @Mandello,
Saw you pop on on the UK boards. Congrats on being smart enough to follow your nose.
If you get a chance, invite old mate Mr FACTS (Ehsan) to come on down and tell us all about those facts he's trying to spruik.
I'd like to discuss his FACTS with him
I'd also like to discuss his potential connections to certain members of the board Maybe you could ask him about his connections to the BOD?
Tell him to come and set us silly kangaroos straight here on HC
Anyone else reading with access to that forum, feel free to issue him the invite."
You lot should be more concerned about us coming over in the winter and taking the Ashes back with us, couldn't beat an Indian B team at home !
It'll be fine, £1 next year ;p
Buy as many shares as you want to....trade on any dip and turn....what ever you want to do ...do
Just take some time over the weekend to study who actually owns any assets in this company , and how much this company is actually worth.....If you have paid 5p a share and therefore valued this company at £110 million then spend an hour or two finding out what you have bought that is actually worth £110 million
Have a look over the weekend at who this company does business with, and who runs those companies
It wont cost you any money to just do the investigating and reading...it is all there ...
at 3.575p you value the company at £78.65m , so if you find it is worth £110m then you should buy more shares that are suggesting it is worth £78m
If you think it will be worth £110m in the future then you have bought future value, whilst others are not willing to pay that yet...hence the share price drop ...others don't want to buy the future at a future price
@jackson
Speak with FACT not lies
This is a fact. just watch these video they explain everything you need to know about past, present and future plus everything else.
*********************************
Watch the MGC Pharma #MXC? webinar hosted by Vox Markets & Turner Pope Investments
https://youtu.be/qikchrfhkho
************************************
MGC Pharma's new head of global sales has big ambitions and says they're 'ready to go'
https://youtu.be/atRbVcHOyeY
***********************************
MGC Pharma – Edison Open House interview
https://youtu.be/itKwpRlACB0
***********************************
MGC Pharma reports 100% success rate in its phase II ArtemiC study in COVID-19
https://youtu.be/04dKV8oDIqU
The FACTS .....that matter !
30th June 2020 - NET TANGIBLE ASSETS PER ORDINARY SHARE (cents) 0.20
31st December 2020 - NET TANGIBLE ASSETS PER ORDINARY SHARE (cents)(0.02) - Negative !!!!!
Ehsan
Just think about that for a minute....a NEGATIVE net tangible assets per share
All the FACTS you need are in the accounts , not in some glossy marketing video..!!
https://wcsecure.weblink.com.au/pdf/MXC/02347635.pdf
The FACTS .....that matter !
30th June 2020 - NET TANGIBLE ASSETS PER ORDINARY SHARE (cents) 0.20
31st December 2020 - NET TANGIBLE ASSETS PER ORDINARY SHARE (cents)(0.02) - Negative !!!!!
Ehsan
Just think about that for a minute....a NEGATIVE net tangible assets per share
All the FACTS you need are in the accounts , not in some glossy marketing video..!!
https://wcsecure.weblink.com.au/pdf/MXC/02347635.pdf
What is your motive on a share board, dissing it? Who do you work for??
@Pokerchips What's your view on this stock? I'm slightly confused now. I ended up selling a few days ago whilst i set up an isa. I'm still looking to get back in however
Poker chips has been floating around this BB since the after the IPO. He's annoyed he missed out the multi bags at the beginning now he's here trying to deramp the share so he can get his buy in price.
we talk with FACTS no LIES
price is down no because of what lies these people telling us. It down because the market is down in general.
FACTS
2020 highlights
1. The 2021 half-year represented a strategically important period for the Group and thus far MGC Pharma has delivered significant progress on an upward growth trajectory as it delivers on its growth strategy.
2. The Group delivered total sales for the half-year of $741,911 in pharma revenue (2019: $134,536).
3. First shipment of MP Line products directly to patients in Brazil. MGC Pharma is the first company globally to ship high THC formulations directly to a patient's door in Brazil
4. $5 million cash grant to establish ArtemiCTM production in Malta. Construction of new facility commenced during the December quarter and will be completed in mid-2021
5. Launch of CannEpil® App
6. Completion of Phase II clinical trial on COVID-19 patients.
The trial met all the FDA requirements for a COVID-19 study including population diversity (age, medical history, and genetic diversity), and demonstrated a full safety profile with no drug-related adverse events.
7. Further successful results from pre-clinical glioblastoma research.
Results from the ongoing pre-clinical research program focused on evaluating cannabinoid formulations in the development of a treatment of the most aggressive and therapeutically resistant brain tumour, glioblastoma, have shown further successful results.
If successful, this would potentially lead to a significant breakthrough in the treatment of brain cancer through oral administration (rather than invasive treatments).
8. Binding term sheet signed for the import and sales of CannEpil® in Israel.
MGC Pharma executed a binding term sheet with IM Cannabis Corp. (IMC), one of the leading cannabis companies in Israel with operations in Europe, for the exclusive wholesale import, sales, and distribution of CannEpil® in Israel.
In Europe, IMC has established a medical cannabis operation first with its distribution subsidiary in Germany and augmented by strategic agreements with EU-GMP standard certified suppliers.
9. $15M Finance Facility
In September 2020, a convertible securities financing agreement was signed with Mercer Street Global Opportunity Fund, LLC ("Mercer"), to provide the Group with funding of up to a total of $15 million.
10. Following the London Stock Exchange listing and associated share placement, the Group is in a strong financial position to pursue identified growth initiatives.
11. With the successful results of phase II clinical trials on ArtemiCTM, a phase III trial is planned to commence in the June quarter.